Present possibilities and future development of Clinical Proteomics;Présent et futur de la Protéomique clinique

Annales de Biologie Clinique

Volumn 65, Issue 5, 2007, Pages 463-471

  Lehmann, Sylvain ^a   Dupuy, Annie ^b   Peoc'h, Katell ^c   Roche, Stéphane ^a   Baudin, Bruno ^d   Quillard, Muriel ^e   Berger, François ^f   Briand, Gilbert ^g   Chwetzoff, Serge ^d   Dine, Gérard ^h   Gonzalo, Philippe ⁱ   Dastugue, Bernard ^j   Sève, Michel ^k   Siest, Gérard ^l   Beaudeux, Jean Louis ^m  

^a HÔPITAL SAINT ELOI   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e ROUEN UNIVERSITY HOSPITAL   (France)

^f HÔPITAL MICHALLON   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h ECOLE CENTRALE PARIS   (France)

ⁱ INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^j UNIVERSITÉ CLERMONT AUVERGNE   (France)

^k GRENOBLE UNIVERSITY HOSPITAL   (France)

^l INSERM   (France)

^m PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

Biomarker; Multiplex; Proteomics

Indexed keywords

BIOLOGICAL MARKER;

FORECASTING; HUMAN; INSTRUMENTATION; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; MICROFLUIDIC ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FORECASTING; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 35349019813     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2007.0149     Document Type: Review

References (13)

1. Kiechle FL, Zhang X. The postgenomic era : implications for the clinical laboratory. Arch Pathol Lab Med 2002 ; 126 : 255-62.
2. Vitzthum F, Behrens F, Anderson NL, Shaw JH. Proteomics : from basic research to diagnostic application. A review of requirements & needs. J Proteome Res 2005 ; 4 : 1086-97.
3. Reynès C, Roche S, Tiers L, et al. Comparison between surface and bead based MALDI profiling technologies using a single bioinformatics algorithm. Clin Proteomics 2007 ; sous presse.
4. Dupuy AM, Lehmann S, Cristol JP. Protein biochip systems for the clinical laboratory. Clin Chem Lab Med 2005 ; 43 : 1291-302.
5. Apple FS, Christenson RH, Valdes R, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem 1999 ; 45 : 199-205.
6. Fitzgerald SP, Lamont JV, McConnell RI, Benchikh el O. Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 2005 ; 51 : 1165-76.
7. Shovman O, Gilburd B, Barzilai O, et al. Evaluation of the BioPlex 2200 ANA screen : analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci 2005 ; 1050 : 380-8.
8. Bruneel A, Labas V, Mailloux A, et al. Proteomic study of human umbilical vein endothelial cells in culture. Proteomics 2003 ; 3 : 714-23.
9. Soldi M, Sarto C, Valsecchi C, et al. Proteome profile of human urine with two-dimensional liquid phase fractionation. Proteomics 2005 ; 5 : 2641-7.
10. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science 2006 ; 312 : 212-7.
11. Rai AJ, Gelfand CA, Haywood BC, et al. HUPO plasma proteome project specimen collection and handling : towards the standardization of parameters for plasma proteome samples. Proteomics 2005 ; 5 : 3262-77.
12. Fung ET, Weinberger SR, Gavin E, Zhang F. Bioinformatics approaches in clinical proteomics. Expert Rev Proteomics 2005 ; 2 : 847-62.
13. Ngo Y, Munteanu M, Messous D, et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006 ; 52 : 1887-96.